Diaz-BuxoJ.A., GotloibL.Agents that modulate peritoneal membrane structure and function.Perit Dial Int2007; 27: 16–30.
2.
NohH., KimJ.S., HanK.H., LeeG.T., SongJ.S., ChungS.H.Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane.Kidney Int2006; 69: 2022–8.
3.
NakayamaM., IzumiG., NemotoY., ShibataK., HasegawaT., NumataM.Suppression of N-(carboxymethyl)lysine generation by antioxidant N-acetylcysteine.Perit Dial Int1999; 19: 207–10.
4.
SchwengerV., MorathC., SalavaA., AmannK., SereginY., DeppischR.Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.J Am Soc Nephrol2006; 17: 199–207.
5.
Official Monographs.In: The United States Pharmacopeia, 29th ed.2006: 51–2.
6.
TrisselL.S.Handbook of Injectable Drugs.13th ed.Bethesda, MD: American Society of Health-System Pharmacists; 2005.
7.
LeggeM., LashG.E., BirdS.D., WalkerR.J.Formaldehyde in heat sterilized peritoneal dialysis solutions: scavenging system for its removal.Perit Dial Int1998; 18: 228–31.
8.
BirdS.D., LeggeM., WalkerR.J.Formaldehyde scavenging from peritoneal dialysis solutions using reduced aminothiol compounds.Nephrology2004; 9: 65–72.
9.
YamamotoT., TomoT., OkabeE., NamotoS., SuzukiK., HiraoY.Glutathione depletion as a mechanism of 3,4-dideoxyglucosone-3-ene-induced cytotoxicity in human peritoneal mesothelial cells: role in biocompatibility of peritoneal dialysis fluids.Nephrol Dial Transplant2009; 24: 1436–42. Epub 25 Nov 2008; doi: 10.1093/ndt/gfn645.
10.
LeeH.B., YuM.R., SongJ.S., HaH.ROS amplify PKC signaling in high glucose-induced fibronectin expression by peritoneal mesothelial cells.Kidney Int2004; 65: 1170–9.